Delivery Order SPE2DB24D2018-SPE2DB25FWWB8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,172.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors. This firm fixed-price delivery order, issued on September 3, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. The award, issued on November 7, 2025, with a completion date of November 10, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,760.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,705.68 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This is a firm fixed-price, non-set-aside contract with a completion date of June 2, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors, with a contract ceiling value of $6,947.95. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.17 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 6, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors, valued at $22,549.80 under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside delivery order. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,183.77 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors, with a completion date of November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWB8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,384.18 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical SPE2DX contract—a $999.99 billion prime indefinite delivery contract running through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to supply a diverse range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. Mounjaro, a diabetes treatment medication, aligns with AmerisourceBergen's demonstrated expertise in delivering specialty medications and brand-name pharmaceuticals to support Defense Health Agency and other federal healthcare customers. The company's consistent receipt of competitively awarded delivery orders, ranging from small-value transactions to substantial orders exceeding $45,000, underscores its established position as a reliable vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 8/6/25 |